Medicus Sciences Acquisition Corp. Warrant
MSACW
MSACW was delisted on the 17th of February, 2023.
18 hedge funds and large institutions have $760K invested in Medicus Sciences Acquisition Corp. Warrant in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
6% more funds holding
Funds holding: 17 → 18 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less capital invested
Capital invested by funds: $925K → $760K (-$165K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$127 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$62 |
MSACW Hedge Fund Activity: Q3 2021 in Review
18 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Warrant (MSACW) for Q3 2021, worth a combined $760K — down 18% from $925K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MSACW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $127. The largest seller was Glazer Capital LLC, cutting an estimated $62.
- 18 institutional investors held Medicus Sciences Acquisition Corp. Warrant (MSACW) as of Q3 2021, up from 17 in Q2 2021.
- Funds reported $760K of Medicus Sciences Acquisition Corp. Warrant stock for Q3 2021, down 18% quarter-over-quarter.
- 1 fund opened new Medicus Sciences Acquisition Corp. Warrant positions in Q3 2021 and 0 closed out, a net change of +1 holder.
- The largest Medicus Sciences Acquisition Corp. Warrant buyer in Q3 2021 was UBS Group, an estimated $127 added.
- The largest Medicus Sciences Acquisition Corp. Warrant seller in Q3 2021 was Glazer Capital LLC, an estimated $62 sold.
Based on aggregated 13F filings for Q3 2021.